Abstract:In the race to combat ever-evolving diseases, the drug discovery process often faces the hurdles of high-cost and time-consuming procedures. To tackle these challenges and enhance the efficiency of identifying new therapeutic agents, we introduce VirtuDockDL, which is a streamlined Python-based web platform utilizing deep learning for drug discovery. This pipeline employs a Graph Neural Network to analyze and predict the effectiveness of various compounds as potential drug candidates. During the validation phase, VirtuDockDL was instrumental in identifying non-covalent inhibitors against the VP35 protein of the Marburg virus, a critical target given the virus’s high fatality rate and limited treatment options. Further, in benchmarking, VirtuDockDL achieved 99% accuracy, an F1 score of 0.992, and an AUC of 0.99 on the HER2 dataset, surpassing DeepChem (89% accuracy) and AutoDock Vina (82% accuracy). Compared to RosettaVS, MzDOCK, and PyRMD, VirtuDockDL outperformed them by combining both ligand- and structure-based screening with deep learning. While RosettaVS excels in accurate docking but lacks high-throughput screening, and PyRMD focuses on ligand-based methods without AI integration, VirtuDockDL offers superior predictive accuracy and full automation for large-scale datasets, making it ideal for comprehensive drug discovery workflows. These results underscore the tool’s capability to identify high-affinity inhibitors accurately across various targets, including the HER2 protein for cancer therapy, TEM-1 beta-lactamase for bacterial infections, and the CYP51 enzyme for fungal infections like Candidiasis. To sum up, VirtuDockDL combines user-friendly interface design with powerful computational capabilities to facilitate rapid, cost-effective drug discovery and development. The integration of AI in drug discovery could potentially transform the landscape of pharmaceutical research, providing faster responses to global health challenges. The VirtuDockDL is available at https://github.com/FatimaNoor74/VirtuDockDL .

Autoparty: Machine Learning-Guided Visual Inspection of Molecular Docking Results

Efficient Exploration of Chemical Space with Docking and Deep Learning

Accelerating Molecular Docking using Machine Learning Methods

Artificial intelligence-enabled virtual screening of ultra-large chemical libraries with deep docking

Streamlining Large Chemical Library Docking with Artificial Intelligence: the PyRMD2Dock Approach

Exploration on Learning Molecular Docking with Deep Learning Models

MILCDock: Machine Learning Enhanced Consensus Docking for Virtual Screening in Drug Discovery

DrugGym: A testbed for the economics of autonomous drug discovery

Deep Surrogate Docking: Accelerating Automated Drug Discovery with Graph Neural Networks

Dockey: a modern integrated tool for large-scale molecular docking and virtual screening

DockM8: An All-in-One Open-Source Platform for Consensus Virtual Screening in Drug Design

Docking Score ML: Target-Specific Machine Learning Models Improving Docking-Based Virtual Screening in 155 Targets

D3CARP: a comprehensive platform with multiple-conformation based docking, ligand similarity search and deep learning approaches for target prediction and virtual screening

Automatic Tailoring and Transplanting: A Practical Method That Makes Virtual Screening More Useful.

Combining Machine Learning Systems and Multiple Docking Simulation Packages to Improve Docking Prediction Reliability for Network Pharmacology

Uni-Mol Docking V2: Towards Realistic and Accurate Binding Pose Prediction

DOCKSTRING: Easy Molecular Docking Yields Better Benchmarks for Ligand Design

Machine Learning-Enabled Pipeline for Large-Scale Virtual Drug Screening

An artificial intelligence accelerated virtual screening platform for drug discovery

Deep Learning Pipeline for Accelerating Virtual Screening in Drug Discovery

Docking-informed machine learning for kinome wide affinity prediction